Target Details
| UniProt AC | P52333 |
|---|---|
| Gene Symbol | JAK3 |
| Protein Name | Tyrosine-protein kinase JAK3 |
| Organism | Homo sapiens |
| Entry Name | |
| Organism Category | Human |
| Pfam Domains | PF18379 (FERM_F1) PF18377 (FERM_F2) PF17887 (Jak1_Phl) PF07714 (PK_Tyr_Ser-Thr) PF21990 (SH2_1) |
Summary
- Multi-target molecules 5,161
- Clinical molecules 45
- Avg pChEMBL 7.57
KEGG Pathways (15)
- Chemokine signaling pathway
- Epstein-Barr virus infection
- Hepatitis B
- Human T-cell leukemia virus 1 infection
- JAK-STAT signaling pathway
- Measles
- Necroptosis
- Non-small cell lung cancer
- PI3K-Akt signaling pathway
- Pathways in cancer
- Primary immunodeficiency
- Signaling pathways regulating pluripotency of stem cells
- Th1 and Th2 cell differentiation
- Th17 cell differentiation
- Viral carcinogenesis
Associated Diseases (1)
Active Molecules (5,161)
| InChIKey | pChEMBL | Type | Targets | Clinical | |
|---|---|---|---|---|---|
FZKHNSXOKWXUHM
|
10.6 | IC50 | 2 | — | |
BSFUWLNZPOVRBF
|
10.6 | IC50 | 2 | — | |
AUWLNQDLZOSAFU
|
10.6 | IC50 | 2 | — | |
UWIRTXHTCICCEB
|
10.6 | IC50 | 2 | — | |
VSCBPDYZLUVMLD
|
10.6 | IC50 | 2 | — | |
HDTXWUHMYZRQFF
|
10.5 | IC50 | 3 | — | |
SLZJYSDUTDXKHL
|
10.5 | IC50 | 2 | — | |
VNDHJWSNDHLJRC
|
10.5 | IC50 | 3 | — | |
GFZLBUBQOPALBK
|
10.5 | IC50 | 2 | — | |
IKOVYVZQLUHKRJ
|
10.5 | IC50 | 2 | — | |
CYEYGIKHGQVFKY
|
10.5 | IC50 | 2 | — | |
VMYNMIVIUVJIHY
|
10.5 | IC50 | 2 | — | |
YHQSZLMVXUELEF
|
10.5 | IC50 | 2 | — | |
OUAVJOGPQUAXTJ
|
10.4 | IC50 | 2 | — | |
XKLPKYDEDWXEAA
|
10.4 | IC50 | 2 | — | |
GLYUNTYKVSBASO
|
10.4 | IC50 | 3 | — | |
HLKWWAPBFBSHJI
|
10.4 | IC50 | 2 | — | |
PEOCEMXAFXTVAE
|
10.4 | IC50 | 2 | — | |
KRHZDZQVASLABQ
|
10.4 | IC50 | 2 | — | |
NCZZXIYJRYNEAO
|
10.4 | IC50 | 3 | — | |
PLRGDPPEBDGPBL
|
10.4 | IC50 | 3 | — | |
BVWLURYOUXNVCD
|
10.4 | IC50 | 2 | — | |
DZVVSKDVSJQTOZ
|
10.4 | IC50 | 2 | — | |
GYZPAKVHBCQCKK
|
10.4 | IC50 | 3 | — | |
KYGMSHBHSDBHRQ
|
10.4 | IC50 | 2 | — | |
SIVNSCOIWZVSSY
|
10.4 | IC50 | 2 | — | |
LNPNJZPJGDLRBR
|
10.3 | IC50 | 2 | — | |
MCRCGCWWWPPTGL
|
10.3 | Kd | 4 | — | |
OIIBZFKNIUFBTG
|
10.3 | IC50 | 2 | — | |
VMYNMIVIUVJIHY
|
10.3 | IC50 | 2 | — | |
CKMFTSBBYPXJFT
|
10.3 | IC50 | 3 | — | |
IOVFFTMQWCOHDE
|
10.3 | Ki | 4 | — | |
JXUVCKRLKKIQLV
|
10.3 | IC50 | 2 | — | |
YAHQISLGSOFLRU
|
10.3 | Ki | 4 | — | |
CAGMYACDPWIQDW
|
10.3 | IC50 | 3 | — | |
GFMSUDIXMJGWQT
|
10.3 | IC50 | 2 | — | |
JKPVBGCJUHOUKU
|
10.3 | IC50 | 2 | — | |
KIDYVTPMDQFDCS
|
10.3 | IC50 | 2 | — | |
KTANGVPPGNDMTF
|
10.3 | IC50 | 3 | — | |
KZTYLBQIWZBZGN
|
10.3 | IC50 | 2 | — | |
MDWNAZJBZGAPCL
|
10.3 | IC50 | 2 | — | |
QXVLADQSKJNARQ
|
10.3 | IC50 | 2 | — | |
RJDFEVIMBGLEBT
|
10.3 | IC50 | 3 | — | |
SIZXITCJPWVYEC
|
10.3 | IC50 | 3 | — | |
WGCLQYPBHLZIGD
|
10.3 | IC50 | 2 | — | |
WRKNUXRARNRWJC
|
10.3 | IC50 | 2 | — | |
XYZMQGQDCDCBRQ
|
10.3 | IC50 | 2 | — | |
KQAJQVQIWBQIFM
|
10.2 | Ki | 4 | — | |
RINWDSCUVKTALQ
|
10.2 | Ki | 4 | — | |
RYVTYSVONAMCBS
|
10.2 | Ki | 4 | — |